JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 22 No. 12 1043-1048
© 1981 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donahue, D. M.
Right arrow Articles by Tunell, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donahue, D. M.
Right arrow Articles by Tunell, W. P.

Thymic Gallium-67 Localization in Pediatric Patients on Chemotherapy: Concise Communication

Diane M. Donahue, Joe C. Leonard, Garo P. Basmadjian, Rupert M. Nitschke, George H. Hinkle, Rodney D. Ice, Don A. Wilson and William P. Tunell

College of Pharmacy, University of Oklahoma, Oklahoma City Campus and Oklahoma Children's Memorial Hospital, Health Sciences Center, Oklahoma City, Oklahoma

Correspondence: For reprints contact: Garo P. Basmadjian, PhD, College of Pharmacy, Univ. of Oklahoma, Oklahoma City Campus, Oklahoma City, OK 73190.

ABSTRACT

Localization of Ga-67 in the thymus has been reported to occur in children. In our control group of 87 patients, 15% of children under 5 yr and 11% of children over 5 yr demonstrated thymic localization. In contrast, in our study group of seven children with acute lymphocytic leukemia or malignant lymphoma, lymphocytic diffuse, treated on a modified non-Hodgkin's lymphoma protocol, Sloan-Kettering LSA2-L2, thymic localization occurred during treatment in five of the seven. We conclude that increased thymic gallium localization in children under chemotherapy for a known malignancy may reflect increased activity of thymic medullary epithelial cells and regeneration of thymic lymphocytes during recovery from involution induced by certain chemotherapeutic agents.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1981 by the Society of Nuclear Medicine.